Regulatory, site management and monitoring services relative to the pivotal phase III trial supporting registration of zoliflodacin, in gonorrhoea

[Published: 7 November, 2017]

GARDP is currently sourcing a Contract Research Organization to assist with US regulatory submissions, US trial sites set-up and management and global monitoring for the pivotal phase III trial supporting registration of zoliflodacin.